Vanguard Group Inc Kronos Bio, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,922,809 shares of KRON stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,922,809

Previous 1,922,809 -0.0%

Holding current value

$1.85 Million

Previous $2.38 Million 19.38%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.73 - $1.38 $18,823 - $35,584	-25,786 Reduced 1.32%	1,922,809 $2.38 Million
Q1 2024 May 10, 2024	BUY	$1.02 - $1.3 $252,876 - $322,293	247,918 Added 14.58%	1,948,595 $2.53 Million
Q4 2023 Feb 14, 2024	BUY	$0.75 - $1.49 $9,234 - $18,344	12,312 Added 0.73%	1,700,677 $2.13 Million
Q3 2023 Nov 14, 2023	BUY	$1.23 - $2.25 $109,470 - $200,250	89,000 Added 5.56%	1,688,365 $2.19 Million
Q2 2023 Aug 14, 2023	BUY	$1.24 - $1.92 $119,720 - $185,374	96,549 Added 6.42%	1,599,365 $2.75 Million
Q1 2023 May 15, 2023	SELL	$1.34 - $2.62 $2,822 - $5,517	-2,106 Reduced 0.14%	1,502,816 $2.19 Million
Q4 2022 Feb 10, 2023	BUY	$1.44 - $3.44 $3,366 - $8,042	2,338 Added 0.16%	1,504,922 $2.44 Million
Q3 2022 Nov 14, 2022	SELL	$3.35 - $5.55 $1.03 Million - $1.7 Million	-307,087 Reduced 16.97%	1,502,584 $5.03 Million
Q2 2022 Aug 12, 2022	SELL	$3.12 - $7.52 $2.47 Million - $5.95 Million	-791,820 Reduced 30.44%	1,809,671 $6.59 Million
Q1 2022 May 13, 2022	SELL	$6.26 - $14.42 $4.95 Million - $11.4 Million	-790,825 Reduced 23.31%	2,601,491 $18.8 Million
Q4 2021 Feb 14, 2022	BUY	$11.35 - $21.18 $665,053 - $1.24 Million	58,595 Added 1.76%	3,392,316 $46.1 Million
Q3 2021 Nov 12, 2021	BUY	$18.17 - $24.7 $6.79 Million - $9.23 Million	373,518 Added 12.62%	3,333,721 $69.9 Million
Q2 2021 Aug 13, 2021	BUY	$20.08 - $29.02 $59.4 Million - $85.9 Million	2,960,203 New	2,960,203 $70.9 Million

Others Institutions Holding KRON

# of Institutions

Shares Held

19.8M

Call Options Held

9.3K

Put Options Held

100

View Full List

About Kronos Bio, Inc.

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $54.5M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

More about KRON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Kronos Bio, Inc. Transaction History